What if stopping your asthma inhaler in early pregnancy did more harm than good? New national study shows continuing inhaled steroid in the first trimester was not linked to worse pregnancy outcomes.

Pregnancy can feel like a string of new rules — especially around medicines. Many people with asthma worry whether inhaler steroids (inhaled corticosteroids — medicines that reduce airway inflammation) could hurt an early pregnancy, so some stop them as soon as they see a positive test. That decision can be wrenching and confusing.

What this new study looked at

A nationwide cohort compared people who were using inhaled corticosteroids (ICS) before pregnancy and either continued or stopped during the first trimester. The researchers reviewed 3,909,084 pregnancies and focused on 6,105 with pre‑pregnancy ICS use; 2,108 continued and 3,997 stopped in early pregnancy. The study found no clear increase in risks—such as preterm birth, low birth weight, or major maternal complications—linked to continuing ICS in the first trimester.

Why that matters for you

Untreated or poorly controlled asthma can reduce oxygen delivery and raise risks like preeclampsia and preterm birth. This study supports existing guidance that keeping asthma under control with inhaler steroids in pregnancy is usually safer than stopping them and risking an asthma flare. The authors say treatment decisions should still be individualized with your clinician.

What to do next (practical steps)

• Talk with your clinician before making any medication changes.

• If you use an inhaled steroid, ask about the specific drug, dose, and how to monitor control.

• Keep an asthma action plan and refill rescue inhalers as instructed.

Medicine Decoded can help you the reasoning behind guideline recommendations on medication use in pregnancy by turning clinical studies (like this JAMA Network Open analysis) into short Study Sheets, exam-style Practice Tests, and spaced-repetition Flashcards to master counseling and risk‑benefit thinking.